Phase 2 Trial of Tremelimumab in Patients With Metastatic Urothelial Cancer Previously Treated With PD-1/PD-L1 Blockade

Status: Closed to Accrual

Learn more:

• clinicaltrials.gov: #NCT03557918

Study Contact: studies@hoosiercancer.org; (317) 921-2050.